Delivery Order SPE2DE24D0013-SPE2D625F2R2C

Award Date 4/11/25
Potential Completion Date 4/18/25
Potential Value $1.4K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $2,208.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting a variety of infectious diseases, including COVID-19, influenza, and sexually transmitted diseases....
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The award, valued at $16,320.00, is a firm fixed-price delivery order contract with no set-aside designation. The contract is for the provision of Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and respiratory...
This is a federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract, valued at $4,539.30, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV),...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is for the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. The contract has a ceiling value of...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The $14,960.00 firm fixed-price delivery order is for the supply of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has no set-aside designation. Cepheid holds several significant federal...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, worth $13,600.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid will provide the DLA with GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is part of...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The $2,551.72 firm fixed-price delivery order is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract does not have a set-aside designation. Cepheid is the prime...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $4,080.00, is a firm fixed-price delivery order that provides the DLA with Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These products and services are used for detecting a variety of infectious diseases, including COVID-19, influenza, and respiratory...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F2R2C
    Delivery Order

This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of diagnostic testing equipment, reagents, and consumables. The contract, valued at $1,361.79, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA). It does not have a set-aside designation.

Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing. Under this contract, the company will provide GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of conditions such as COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. This contract is part of Cepheid's larger portfolio of federal contract vehicles, including Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs (VA) and Indian Health Service, enabling these agencies to continuously procure Cepheid's molecular diagnostic solutions.

Generated 7/11/25, 10:14 AM